Mhr Fund Management LLC Iovance Biotherapeutics, Inc. Transaction History
Mhr Fund Management LLC
- $669 Million
- Q1 2025
A detailed history of Mhr Fund Management LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Mhr Fund Management LLC holds 24,417,103 shares of IOVA stock, worth $44.7 Million. This represents 12.15% of its overall portfolio holdings.
Number of Shares
24,417,103
Previous 24,417,103
-0.0%
Holding current value
$44.7 Million
Previous $181 Million
55.0%
% of portfolio
12.15%
Previous 24.02%
Shares
4 transactions
Others Institutions Holding IOVA
# of Institutions
337Shares Held
247MCall Options Held
1.34MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA27.8MShares$50.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$38.8 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY12.7MShares$23.3 Million1.77% of portfolio
-
State Street Corp Boston, MA11MShares$20.2 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR9.25MShares$16.9 Million1.07% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $289M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...